Abstract: The invention relates to new pharmaceutical compositions intended for administration by ocular route and to the process for obtaining them.A specific subject of the invention is a process for obtaining pharmaceutical compositions intended for ophthalmic route of which the active ingredient is bromocriptine, in which the active ingredient is dissolved in methanol then this solution is diluted with an aqueous solute containing a hydrosoluble inert filler, the mixture is lyophilized then the lyophilization deposit is redissolved at the time of use in an aqueous solute containing a preservative, a polyethylene glycol, physiological serum and an ethylenic acid.The solute obtained is a medicament for intra-ocular hypertension.

Abstract: In a distributing device for liquid preparation composed of three parts forming a single unit consisting of a receptacle, an intermediate part of a flexible texture forming a bellows fixed on the neck of the receptacle and an upper part mounted on the top of the bellows forming a reservoir finished by a nozzle closed at its ends. The intermediate part is composed of a flexible sleeve formed of several concentric rings joined together, inside which are arranged two impervious membranes separated by a rigid member having two sharpened extremities arranged vertically, perpendicular to each of the two membranes.

Abstract: This invention relates to the field of pharmaceutical chemistry and more precisely to the field of galenical pharmacy.It refers to new pharmaceutical compositions intended for the buccal tract, the active ingredient of which is lysine acetylsalicylate in association or mixed with one or several excipients and/or diluents adapted to achieve a pharmaceutical form which may be sucked or chewed. A process for the production of said pharmaceutical composition is also described.

Abstract: This invention relates to a novel process for solubilizing the hydrophobic organic compounds--and namely the pharmaceutical active ingredients--in an aqueous phase.This process is defined in that the hydrophobic compound is prior dissolved in one or several polymers of high molecular weight, then adding to this solution an aqueous medium the pH of which is fixed.The aqueous solutions thus resulting are useful for preparing medicines for parenteral, digestive, mucous or transcutaneous administration.